Statistics South Africa: Mortality and causes of death in South Africa, 2010: Findings from death notification. 2013, P0309.3.
Google Scholar
World Health Organization: The Global Tuberculosis Control Report 2012. Geneva: World Health Organization; 2012.
Google Scholar
Kabra SK, Lodha R, Seth V: Some current concepts on childhood tuberculosis. Indian J Med Res 2004,120(4):387–397.
CAS
PubMed
Google Scholar
Swaminathan S, Rekha B: Pediatric tuberculosis: global overview and challenges. Clin Infect Dis 2010,50(Suppl 3):S184-S194.
Article
PubMed
Google Scholar
Nelson LJ, Wells CD: Global epidemiology of childhood tuberculosis. Int J Tuberc Lung Dis 2004,8(5):636–647.
CAS
PubMed
Google Scholar
Donald PR: Childhood tuberculosis: out of control? Curr Opin Pulm Med 2002,8(3):178–182. 10.1097/00063198-200205000-00005
Article
PubMed
Google Scholar
Department of Health: Republic of South Africa: Joint Review of HIV, TB and PMTCT Programmes in South Africa. Pretoria: Department of Health; 2014.
Google Scholar
Brewer TF: Preventing tuberculosis with bacillus Calmette-Guerin vaccine: a meta-analysis of the literature. Clin Infect Dis 2000,31(Suppl 3):S64-S67.
Article
PubMed
Google Scholar
Colditz GA, Berkey CS, Mosteller F, Brewer TF, Wilson ME, Burdick E, Fineberg HV: The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics 1995,96(1 Pt 1):29–35.
CAS
PubMed
Google Scholar
Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg HV, Mosteller F: Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 1994,271(9):698–702. 10.1001/jama.1994.03510330076038
Article
CAS
PubMed
Google Scholar
Fine PE: Variation in protection by BCG: implications of and for heterologous immunity. Lancet 1995,346(8986):1339–1345. 10.1016/S0140-6736(95)92348-9
Article
CAS
PubMed
Google Scholar
Rodrigues LC, Diwan VK, Wheeler JG: Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. Int J Epidemiol 1993,22(6):1154–1158. 10.1093/ije/22.6.1154
Article
CAS
PubMed
Google Scholar
Trunz BB, Fine P, Dye C: Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet 2006,367(9517):1173–1180. 10.1016/S0140-6736(06)68507-3
Article
PubMed
Google Scholar
van Rie A, Beyers N, Gie RP, Kunneke M, Zietsman L, Donald PR: Childhood tuberculosis in an urban population in South Africa: burden and risk factor. Arch Dis Child 1999,80(5):433–437. 10.1136/adc.80.5.433
Article
CAS
PubMed Central
PubMed
Google Scholar
Dye C, Garnett GP, Sleeman K, Williams BG: Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Directly observed short-course therapy. Lancet 1998,352(9144):1886–1891. 10.1016/S0140-6736(98)03199-7
Article
CAS
PubMed
Google Scholar
Abu-Raddad LJ, Sabatelli L, Achterberg JT, Sugimoto JD, Longini IM Jr, Dye C, Halloran ME: Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics. Proc Natl Acad Sci U S A 2009,106(33):13980–13985. 10.1073/pnas.0901720106
Article
CAS
PubMed Central
PubMed
Google Scholar
Young D, Dye C: The development and impact of tuberculosis vaccines. Cell 2006,124(4):683–687. 10.1016/j.cell.2006.02.013
Article
CAS
PubMed
Google Scholar
McShane H: Tuberculosis vaccines: beyond bacille Calmette-Guerin. Philos Trans R Soc Lond B Biol Sci 2011,366(1579):2782–2789. 10.1098/rstb.2011.0097
Article
CAS
PubMed Central
PubMed
Google Scholar
Odutola AA, Owolabi OA, Owiafe PK, McShane H, Ota MO: A new TB vaccine, MVA85A, induces durable antigen-specific responses 14 months after vaccination in African infants. Vaccine 2012,30(38):5591–5594. 10.1016/j.vaccine.2012.06.054
Article
CAS
PubMed
Google Scholar
Scriba TJ, Tameris M, Mansoor N, Smit E, van der Merwe L, Mauff K, Hughes EJ, Moyo S, Brittain N, Lawrie A, Mulenga H, de Kock M, Gelderbloem S, Veldsman A, Hatherill M, Geldenhuys H, Hill AV, Hussey GD, Mahomed H, Hanekom WA, McShane H: Dose-finding study of the novel tuberculosis vaccine, MVA85A, in healthy BCG-vaccinated infants. J Infect Dis 2011,203(12):1832–1843. 10.1093/infdis/jir195
Article
CAS
PubMed
Google Scholar
Tameris MD, Hatherill M, Landry BS, Scriba TJ, Snowden MA, Lockhart S, Shea JE, McClain JB, Hussey GD, Hanekom WA, Mahomed H, McShane H, MVA85A 020 Trial Study Team: Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. Lancet 2013,381(9871):1021–1028. 10.1016/S0140-6736(13)60177-4
Article
CAS
PubMed
Google Scholar
Kritzinger FE, den Boon S, Verver S, Enarson DA, Lombard CJ, Borgdorff MW, Gie RP, Beyers N: No decrease in annual risk of tuberculosis infection in endemic area in Cape Town. South Africa. Trop Med Int Health 2009,14(2):136–142. 10.1111/j.1365-3156.2008.02213.x
Article
PubMed
Google Scholar
Middelkoop K, Bekker LG, Myer L, Dawson R, Wood R: Rates of tuberculosis transmission to children and adolescents in a community with a high prevalence of HIV infection among adults. Clin Infect Dis 2008,47(3):349–355. 10.1086/589750
Article
PubMed
Google Scholar
Shanaube K, Sismanidis C, Ayles H, Beyers N, Schaap A, Lawrence KA, Barker A, Godfrey-Faussett P: Annual risk of tuberculous infection using different methods in communities with a high prevalence of TB and HIV in Zambia and South Africa. PLoS One 2009,4(11):e7749. 10.1371/journal.pone.0007749
Article
PubMed Central
PubMed
CAS
Google Scholar
Wood R, Liang H, Wu H, Middelkoop K, Oni T, Rangaka MX, Wilkinson RJ, Bekker LG, Lawn SD: Changing prevalence of tuberculosis infection with increasing age in high-burden townships in South Africa. Int J Tuberc Lung Dis 2010,14(4):406–412.
CAS
PubMed Central
PubMed
Google Scholar
Statistics South Africa: Western Cape TB Mortality Data Children 0–10 years (2005–2009).
World Health Organization Global Health Observatory (GHO): South Arica Life Tables 2009. Geneva: World Health Organization; 2009.
Google Scholar
Corrigall J, Coetzee D, Cameron N: Is the Western Cape at risk of an outbreak of preventable childhood diseases? Lessons from an evaluation of routine immunisation coverage. S Afr Med J 2008,98(1):41–45.
PubMed
Google Scholar
Immunisation drop-out rate (DTP3-measles), July 2007 [http://indicators.hst.org.za/healthstats/239/data]
Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB: Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA 1996,276(15):1253–1258. 10.1001/jama.1996.03540150055031
Article
CAS
PubMed
Google Scholar
Kim SY, Goldie SJ, Salomon JA: Cost-effectiveness of Rotavirus vaccination in Vietnam. BMC Public Health 2009, 9: 29–2458–9-29.
Google Scholar
Kim SY, Lee G, Goldie SJ: Economic evaluation of pneumococcal conjugate vaccination in The Gambia. BMC Infect Dis 2010, 10: 260–2334–10–260.
Google Scholar
Sinanovic E, Moodley J, Barone MA, Mall S, Cleary S, Harries J: The potential cost-effectiveness of adding a human papillomavirus vaccine to the cervical cancer screening programme in South Africa. Vaccine 2009,27(44):6196–6202. 10.1016/j.vaccine.2009.08.004
Article
PubMed
Google Scholar
Mandalakas AM, Hesseling AC, Gie RP, Schaaf HS, Marais BJ, Sinanovic E: Modelling the cost-effectiveness of strategies to prevent tuberculosis in child contacts in a high-burden setting. Thorax 2013,68(3):247–255. 10.1136/thoraxjnl-2011-200933
Article
PubMed
Google Scholar
Statistics South Africa Consumer Price Index (CPI) Historical Data [http://beta2.statssa.gov.za/publications/P0141/CPIHistory.pdf]
South African Reserve Bank Historical Exchange Rates (daily) [https://wwwrs.resbank.co.za/webindicators/ExchangeRateDetail.aspx?DataItem=EXCX135D]
Drummond M: Methods for the Economic Evaluation of Health Care Programmes. 3rd edition. New York: Oxford University Press; 2005.
Google Scholar
Griffiths UK, Hutton G, Das Dores Pascoal E: The cost-effectiveness of introducing hepatitis B vaccine into infant immunization services in Mozambique. Health Policy Plan 2005,20(1):50–59. 10.1093/heapol/czi006
Article
PubMed
Google Scholar
Day C, Barron P, Massyn N, Padarath A, English R: District Health Barometer 2010/2011. Durban: Health Systems Trust; 2012.
Google Scholar
Ditkowsky JB, Schwartzman K: Potential cost-effectiveness of a new infant tuberculosis vaccine in South Africa–implications for clinical trials: a decision analysis. PLoS One 2014,9(1):e83526. 10.1371/journal.pone.0083526
Article
PubMed Central
PubMed
CAS
Google Scholar
Tseng CL, Oxlade O, Menzies D, Aspler A, Schwartzman K: Cost-effectiveness of novel vaccines for tuberculosis control: a decision analysis study. BMC Public Health 2011, 11: 55–2458–11–55.
Article
Google Scholar
Ziv E, Daley CL, Blower S: Potential public health impact of new tuberculosis vaccines. Emerg Infect Dis 2004,10(9):1529–1535. 10.3201/eid1009.030921
Article
PubMed Central
PubMed
Google Scholar